用于局部免疫治疗的T淋巴细胞捕获DNA网络
Chi Yao1, Chenxu Zhu1, Jianpu Tang1
1Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE), Institute of Biomolecular and Biomedical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, People's Republic of China.
Journal of the American Chemical Society
|November 15, 2021
概括
研究人员开发了一种DNA网络来分离T细胞, 这种纳米生物技术具有高纯度和可行性, 能够有效地局部化治疗癌症.
科学领域:
- 生物技术
- 纳米技术
- 免疫学
背景情况:
- 在免疫疗法中有效分离纯活性的免疫细胞至关重要,但仍然具有挑战性.
- 目前的方法往往会导致细胞损伤,
研究的目的:
- 开发一种基于DNA的新型纳米生物技术,用于T淋巴细胞 (T细胞) 的特定隔离和现场化.
- 能够释放T细胞和免疫辅助剂以进行局部免疫治疗.
主要方法:
- 通过酶放大合成具有功能多元模块 (细胞,免疫辅助剂) 的超长DNA链.
- 通过补充序列形成DNA网络,用于T细胞封装和随后的酶介导释放.
- 将含有T细胞的DNA网络用于局部免疫治疗的瘤病变.
主要成果:
- 捕获的瘤透T细胞的高纯度 (98%) 保持活力 (∼90%).
- 通过将T细胞DNA网络注射到瘤部位,证明成功的局部免疫疗法.
结论:
- 开发的DNA网络提供了强大的纳米生物技术,
- 这种方法有望通过改善细胞处理和局部治疗来推进免疫治疗.
相关概念视频
Tumor Immunotherapy
726
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
726
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K


